Deltex Medical Group (Deltex Medical Group) Debt-to-Equity : 0.58 (As of Dec. 2023)

View and export this data going back to 2009. Start your Free Trial

What is Deltex Medical Group Debt-to-Equity?

Deltex Medical Group's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $0.17 Mil. Deltex Medical Group's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $2.26 Mil. Deltex Medical Group's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $4.16 Mil. Deltex Medical Group's debt to equity for the quarter that ended in Dec. 2023 was 0.58.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Deltex Medical Group's Debt-to-Equity or its related term are showing as below:

DTXMF' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.44 Med: 0.74 Max: 1.26
Current: 0.58

During the past 13 years, the highest Debt-to-Equity Ratio of Deltex Medical Group was 1.26. The lowest was 0.44. And the median was 0.74.

DTXMF's Debt-to-Equity is ranked worse than
75.39% of 699 companies
in the Medical Devices & Instruments industry
Industry Median: 0.22 vs DTXMF: 0.58

Deltex Medical Group Debt-to-Equity Historical Data

The historical data trend for Deltex Medical Group's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Deltex Medical Group Debt-to-Equity Chart

Deltex Medical Group Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

0.58

0.53

0.99

0.95

0.58

Deltex Medical Group Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Debt-to-Equity	Get a 7-Day Free Trial															0.99	0.73	0.95	1.20	0.58

Competitive Comparison of Deltex Medical Group's Debt-to-Equity

For the Medical Devices subindustry, Deltex Medical Group's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Deltex Medical Group's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Deltex Medical Group's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Deltex Medical Group's Debt-to-Equity falls into.

Deltex Medical Group Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Deltex Medical Group's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.173	+	2.258)	/	4.163
	=	0.58

Deltex Medical Group's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0.173	+	2.258)	/	4.163
	=	0.58

Deltex Medical Group (OTCPK:DTXMF) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Deltex Medical Group Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Deltex Medical Group's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Deltex Medical Group (Deltex Medical Group) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Deltex Medical Group PLC (OTCPK:DTXMF) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

DEMG:UK

Address

Terminus Road, Chichester, W Sussex, GBR, PO19 8TX

Website

https://www.deltexmedical.com/

Deltex Medical Group PLC is a British manufacturer of Fluid Management devices, which include the ODM and now ODM+ haemodynamic monitoring systems. It has developed the gold standard for haemodynamic monitoring with its oesophageal Doppler technology, which is marketed as TrueVue Doppler and often generically referred to by clinicians as ODM. The company's initial and principal technology is Doppler-based ultrasound oesophageal haemodynamic monitoring. This technology generates accurate, real-time data on descending aortic blood flow velocity in anesthetised or sedated patients.

Deltex Medical Group (Deltex Medical Group) Headlines

No Headlines